Reducing heart failure events via individualized patient education program in patients with reduced ejection fraction

Anu Philip1, Chakrakodi Shasidhara Shastry1, Basavaraj Utagi2

  • 1Department of Pharmacy Practice, NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Nitte (Deemed to be University), Mangalore 575018, India.

Insights

An individualized patient education program (IPEP) significantly reduced heart failure rehospitalization rates and improved quality of life for patients with reduced ejection fraction (HFrEF). This patient education program enhanced self-care practices and medication adherence.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Heart failure (HF) disease management programs improve clinical outcomes through medication management and lifestyle changes.
  • Reduced ejection fraction (HFrEF) requires specialized patient education for effective management.
  • Standard care in HF may not fully address patient self-care needs.

Purpose of the Study:

  • To evaluate the effectiveness of an individualized patient education program (IPEP) for patients with HFrEF.
  • To assess the impact of IPEP on clinical outcomes, self-care practices, medication adherence, and quality of life.
  • To determine the role of academic pharmacists in delivering patient education for HFrEF.

Main Methods:

  • Prospective interventional study with 164 patients randomized into control (CG) and intervention (IG) groups.
  • The IG received IPEP from an academic pharmacist, while both groups received standard care.
  • Outcomes including self-care, medication adherence, quality of life, and rehospitalization were assessed at 6 and 12 months using statistical analyses.

Main Results:

  • The 1-year rehospitalization rate was significantly lower in the IG (33%) compared to the CG (48%) (HR=0.55, p=0.018).
  • Kaplan-Meier analysis showed a significantly lower rehospitalization rate in the IG over time (log-rank P=0.017).
  • The IG demonstrated significant improvements in self-care practices, medication adherence, and quality of life at 6 and 12 months (p ≤ 0.001).

Conclusions:

  • An individualized patient education program (IPEP) delivered by an academic pharmacist is effective for HFrEF management.
  • IPEP significantly reduces one-year rehospitalization rates in patients with HFrEF.
  • IPEP enhances patient self-care, medication adherence, and quality of life.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
378
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
338
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
314
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
293
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K